Skip to main content

Fiscal Wizard · Single-issue tearsheet

SOLV / Jun 22, 2026 Run #7645

SOLV

Solventum Corporation

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Composite verdict

A 78.6 / 100
Bullish setup · Reversal 11 drivers · 3 gates blocking
  • Williams %R
  • MA Rejection
  • Keltner Channels
Consider long call target Δ ~0.70 · ~35 DTE Bullish setup, Grade A → ITM call target

Industry rank 2nd of 57 in Medical Instruments & Supplies

rescore-sweep
Technical synthesisRegime: volatile uptrend
Bull 100%Evidence: High · 15 signals0% Bear
Momentum Bullish 85Mean-reversion Bullish 62
  • Pullback buyOversold in an uptrend — a pullback buy: mean-reversion aligned with the primary trend, the high-value case for an oversold signal. (medium confidence)
Where value comes fromMargin of safety -52%
Asset value $29.16Earnings power value $103.11Price $75.43

The discount is mostly unpriced earnings power: price ($75.43) sits between asset value ($29.16) and no-growth earnings power value ($103.11).

Fundamentals Above average

58.6 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
Margin of Safety 0
Earnings Yield 97
OCF to Net Income 0
Greenblatt ROC 91
Free Cash Flow Yield 0

Technicals Bullish

98.6 / 100

Bullish setup leads (Williams %R, MA Rejection, Keltner Channels); bears gated by guards. · 43 signals shown.

Strongest
Weakest
Williams %R 93
MA Rejection 83
Keltner Channels 80

Risk Gates

3 blocking 8 caution

3 guards active, 26 signals gated.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Realized Volatility Regime Blocking

High-vol regime mutes mean-reversion signals; low-vol regime mutes breakout signals.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Altman Z-Score Caution

Bottom-band Altman Z blocks bullish signals — distress risk.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for SOLV.